No headlines found.
VanEck Announces Year-End Distributions for VanEck Equity ETFs
Business Wire (Fri, 19-Dec 8:24 PM ET)
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
Vaneck Biotech ETF trades on the NASDAQ stock market under the symbol BBH.
As of February 6, 2026, BBH stock price climbed to $197.14 with 804 million shares trading.
BBH has a market cap of $391.62 million. This is considered a Small Cap stock.
In the last 3 years, BBH traded as high as $202.91 and as low as $135.34.
BBH has outperformed the market in the last year with a return of +17.4%, while the SPY ETF gained +14.4%. In the last 3 month period, BBH beat the market returning +9.5%, while SPY returned +1.3%. However, in the most recent 2 weeks BBH has underperformed the stock market by returning -0.8%, while SPY returned -0.7%.
BBH support price is $192.13 and resistance is $197.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BBH shares will trade within this expected range on the day.
